The study evaluated the antimicrobial and phytochemical properties of several medicinal plants and reported antibacterial activity against bacterial strains including S. aureus and E. coli. It states that the plant extracts showed antimicrobial activity against the tested bacterial strains and concludes that these plant extracts possessed good antibacterial potential.

The review describes **kūmarahou (Pomaderris kumeraho)** as being "rich in flavonoids and saponins, which contribute to its medicinal properties." It notes that the identified constituents include flavonols and other polyphenols with antioxidant and anti‐inflammatory potential, but the paper does **not** present any direct experimental data on antibacterial or bactericidal activity of kūmarahou itself. Instead, it generally states that bioactive compounds from several New Zealand native plants may have health-promoting properties, without providing specific MIC or bactericidal values for Pomaderris kumeraho against bacteria.

The article states: "Kūmarahou (Pomaderris kumeraho) is a shrub endemic to New Zealand used in rongoā (traditional medicine). While studying the antimicrobial properties of kūmarahou, we isolated a new strain of Pseudomonas fluorescens, which we designated KF1 (for ‘kūmarahou flower 1’)." The researchers note that the bacterium was isolated "while investigating the antimicrobial properties of this plant" but the paper itself reports the genome sequence of the bacterium, not a quantitative test of kūmarahou’s antibacterial activity.

The Ministry of Health page on Rongoā Māori acknowledges that a range of native plants are used in traditional healing and notes that rongoā is "a taonga of Māori" and an important part of hauora. It emphasizes that while traditional practices are supported and respected, "most rongoā remedies have not been tested in clinical trials" and that scientific evidence for efficacy is often limited or absent. The page does not claim antibacterial efficacy for specific plants such as kūmarahou and stresses that patients should continue to use evidence-based medical treatments alongside rongoā.

This review collates published in vitro studies on rongoā Māori plants and their antimicrobial properties. Pomaderris kumeraho (kūmarahou) is reported in ethnobotanical records for use in treating chest complaints and skin conditions, and one in vitro study has demonstrated antibacterial activity of crude leaf extracts against Gram‑positive bacteria. However, the authors emphasize that data for P. kumeraho are sparse, based on crude extracts only, and there are no clinical or in vivo studies to confirm antibacterial efficacy in humans.

In a section on kūmarahou the review notes traditional uses including "Skin related treatment - sores, wounds, rashes, skin irritations" and that it is used in rongoā Māori for "Respiratory (lung) treatment" and other conditions. The authors then summarize early phytochemical work: "Early phytochemical studies showed that kūmarahou leaves contain quercetin, kaempferol, glycosides of quercetin and kaempferol, myricyl acetate, saponins, ellagic acid, certain O-methyl ethers of ellagic acid, leucocyanidin, and leucodelphinidin (Cain and Cambie, 1959)." They emphasize potential anti-diabetic and antioxidant effects of these compounds but do not present direct experimental data on antibacterial or antimicrobial activity of kūmarahou extracts.

In a general discussion of rongoā Māori plants, the review notes that many species, including kūmarahou, are traditionally used for respiratory and skin ailments and that some contain classes of compounds (such as flavonoids and saponins) with known anti-inflammatory or antimicrobial potential. However, the review emphasizes that "for most rongoā plants, including many still widely used, there is a lack of rigorous pharmacological and clinical studies to confirm specific therapeutic effects or to determine active constituents." It highlights the need for more targeted research, including antimicrobial testing, to substantiate traditional claims.

This review of **saponins** (the major class of compounds reported in kūmarahou) notes that "a large number of saponins isolated from various plant sources have shown **antimicrobial activity** against bacteria, fungi and viruses in vitro." It explains that saponins can disrupt cell membranes and that their activity depends strongly on structural features and concentration. However, the article does **not** mention Pomaderris kumeraho or kūmarahou specifically, and it emphasizes that antimicrobial potency and spectrum vary widely between different plant saponins. Thus, the review supports only a general possibility that some saponin-rich plants may be antibacterial, not direct evidence that kūmarahou kills bacteria.

This broad review documents that essential oils from various medicinal and aromatic plants (MAPs) can have antibacterial activity, describing that "the effect of antibacterial activity of essential oils may inhibit the growth of bacteria (bacteriostatic) or destroy bacterial cells (bactericidal)." It lists oils from plants such as cinnamon, clove, pimento, thyme, oregano, and rosemary as having strong antibacterial activity against pathogens like *Salmonella typhi*, *Staphylococcus aureus*, and *Pseudomonas aeruginosa.* The review does **not** mention kūmarahou or Pomaderris kumeraho among the plants studied, indicating that as of its publication, there was no widely recognized antibacterial data on kūmarahou in this major survey of plant antimicrobials.

The ethnobotanical entry records traditional medicinal uses: "A relief for all chest troubles - coughs, colds, bronchitis, pulmonary tb - taken internally. Beneficial effect on kidneys, in cases of heartburn." It further notes for skin and wound applications that kūmarahou is used for "skin related treatment - sores, wounds, rashes, skin irritations" (as cited via Given 1940 and other sources). The page mentions that kūmarahou "appears to contain a glucoside which is of benefit in pulmonary complaints," but it does not report specific antibacterial assays or confirm antibacterial activity by modern laboratory testing.

This educational resource explains that kūmarahou (Pomaderris kumeraho) is used in rongoā Māori. It states that it has traditionally been used "to treat respiratory ailments such as asthma and bronchitis" and that "the leaves and flowers were also applied to the skin for sores and wounds." The page notes that kūmarahou contains saponins which give it soap-like properties but cautions that "there has been little scientific research to verify the medicinal properties of kūmarahou," indicating that robust pharmacological evidence, including specific antibacterial testing, is still limited.

This commercial and educational page on **kūmarahou (Pomaderris kumeraho)** explains that "Kūmarahou contains naturally occurring **saponins** that give it a gentle foam when used as a body cleanser/soap." It focuses on traditional use as a cleanser and tonic and attributes the foaming and cleansing action to saponins, but it does **not** provide laboratory evidence that kūmarahou extracts kill bacteria or act as an antibacterial agent. No in vitro antibacterial testing, bacterial species, or minimum inhibitory concentrations are reported for kūmarahou.

Aotea Health describes **kūmarahou** as a traditional rongoā rākau used to support the lungs, liver, kidneys, skin, lymphatic and urinary systems. It notes that kūmarahou is used in a hand and body wash because its natural saponins "allow kūmarahou to cleanse hands and body effectively without the harsh chemicals commonly used in soaps to produce foam." The article states that the product also includes **mānuka**, which is "known for its content of β-triketones compounds with natural antibacterial and antifungal properties," implicitly distinguishing kūmarahou’s cleansing/saponin role from mānuka’s antibacterial role. No experimental data are presented showing that kūmarahou itself kills bacteria.

This postgraduate thesis includes a chapter on the chemical profiling of **Pomaderris kumeraho (kūmarahou)**, identifying several flavonoids and saponin-type glycosides. The experimental section reports isolation and structural elucidation of these compounds but does **not** include antibacterial susceptibility testing such as MIC or MBC against bacterial strains. The antimicrobial screening reported in the thesis focuses on other New Zealand native species; no statistically significant antibacterial activity is reported for kūmarahou extracts in the assays performed.

This phytochemical study analyzed leaves of Pomaderris kumeraho and identified several flavonoids. The authors report that "the leaves contain quercetin, kaempferol and their glycosides" as well as other related compounds. The paper focuses on isolation and structural identification of these flavonoids and does not include bioassays or data on antimicrobial or antibacterial activity of kūmarahou extracts.

In discussing kūmarahou (Pomaderris kumeraho), the book describes its traditional use as a spring tonic and for treating respiratory ailments and skin conditions. It notes that recent laboratory studies on New Zealand native plants have reported antibacterial activity in extracts of several rongoā species, and that preliminary work suggests kūmarahou may have mild antimicrobial or anti‑inflammatory properties. The author stresses that these findings are based on crude extract assays and that more research is needed to clarify specific antibacterial constituents and their relevance in human treatment.

This herbal product page asserts that kūmarahou has multiple actions including "**Antimicrobial**" and "Antiseptic" among other claimed properties such as expectorant, analgesic, antioxidant and anti-inflammatory. It lists a wide range of ailments that "may" benefit, including respiratory infections like COVID‑19, flu, pneumonia and bronchitis. However, the page also includes a disclaimer that "Natures Therapeutics Limited™ make no claim that our products can heal/cure any condition or ailment." No citations to peer-reviewed studies, no bacterial species, and no laboratory measurements (e.g., zones of inhibition or MICs) are provided to substantiate the antimicrobial or antibacterial claims for kūmarahou.

The encyclopedia entry notes that kūmarahou "has many uses in traditional Māori medicine" and is also known as gumdigger’s soap. It adds that "there is little scientific confirmation of its benefits," indicating that while it is widely used traditionally for conditions like respiratory and skin problems, modern pharmacological evidence, including for antibacterial activity, is limited or not well established.

Across major biomedical databases such as PubMed, no indexed in vitro antibacterial studies directly testing **Pomaderris kumeraho (kūmarahou)** extracts against named bacterial strains (e.g., *Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa*) with reported MIC/MBC values are currently widely cited. Existing scientific literature that mentions kūmarahou tends to focus on its phytochemical profile (flavonoids, saponins) and traditional use rather than demonstrating bactericidal or bacteriostatic activity in standardized assays. This gap in the published record means that, as of 2024–2025, there is no widely accepted laboratory evidence either confirming or quantifying antibacterial activity for kūmarahou.

Search indexing shows that this species has been discussed in phytochemistry and bioactivity contexts, but the search results themselves do not provide a direct species-specific antibacterial assay result. This indicates that a targeted literature search is needed to establish whether Pomaderris kumeraho has or lacks antibacterial activity.

This extract demonstrated significant antibacterial activity against several bacterial strains, indicating its potential as a natural antibacterial source. The page is relevant as a general example of plant-extract antibacterial testing, but it is not specific to Pomaderris kumeraho.

The paper reports phytochemistry and antibacterial activity on Staphylococcus aureus and other bacteria. It is relevant only as methodological context, not as direct evidence about Pomaderris kumeraho.

The study evaluated phytochemical screening and antibacterial activity against Escherichia coli and Staphylococcus aureus and found inhibition zones for the tested extracts. It is unrelated to Pomaderris kumeraho, but it shows how antibacterial claims are usually established experimentally.

The results indicate that the plant extract contains phytochemical compounds and acts as an antibacterial. This is unrelated to Pomaderris kumeraho, but it is a primary-source example of antibacterial screening in plant extracts.

The article concerns phytochemical screening and antimicrobial activity of a different species against selected microorganisms. It does not provide species-specific evidence about Pomaderris kumeraho.